Are taxanes more effective than 5FU in combination chemotherapy for recurrent and metastatic head and neck cancer?

Iqbal, Muhammad Shahid; Kovarik, Josef; Patil, Rahul; Kelly, Charles G

Iqbal, Muhammad Shahid; Kovarik, Josef; Patil, Rahul; Kelly, Charles G.

Afiliação

Iqbal MS; Department of Clinical Oncology, Northern Centre of Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK. Electronic address: Shahid.Iqbal@nhs.net.
Kovarik J; Department of Clinical Oncology, Northern Centre of Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.
Patil R; Department of Clinical Oncology, Northern Centre of Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.
Kelly CG; Department of Clinical Oncology, Northern Centre of Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.

Oral Oncol ; 124: 105455, 2022 01.

Article em En | MEDLINE | ID: mdl-34253464

Assuntos

Neoplasias de Cabeça e Pescoço; Taxoides; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Cetuximab; Quimioterapia Combinada; Fluoruracila/uso terapêutico; Neoplasias de Cabeça e Pescoço/tratamento farmacológico; Humanos; Recidiva Local de Neoplasia/tratamento farmacológico; Taxoides/uso terapêutico

Palavras-chave

5FU; Cetuximab; Head and neck cancer; Palliative chemotherapy; Platinum; Taxanes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Taxoides / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Taxoides / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2022 Tipo de documento: Article